Celldex Therapeutics Inc (NASDAQ:CLDX)

26.76
Delayed Data
As of Apr 17
 -0.99 / -3.57%
Today’s Change
10.76
Today|||52-Week Range
32.82
+46.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-44.8M-59.1M-81.6M-118.1M
 
 
 
 
 
Depreciation4.2M3.1M2.9M3.4M
 
 
 
 
 
Total Other Cash Flow2.6M1.8M3.3M7.0M
 
 
 
 
 
Funds From Operations-38.0M-54.2M-75.3M-107.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.4M-4.4M-7.7M-6.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-35.7M-49.8M-67.7M-101.5M
 
 
 
 
 
 
InvestingIncrease In Investments-52.7M-69.3M-112.1M-148.3M
 
 
 
 
 
Decrease In Investments51.0M52.4M38.9M109.2M
 
 
 
 
 
Capital Expenditures-509.0K-303.0K-4.2M-1.9M
 
 
 
 
 
Fixed Asset Disposal68.0K218.0K21.0K0.00
 
 
 
 
Net Cash Flow Investing-2.2M-17.0M-77.4M-41.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings5.0M0.000.000.00
 
 
Long Term Debt Reduction-12.5M-4.0M-11.0M0.00
 
 
 
 
Net Proceeds Stock Sale36.0M83.8M295.7M0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.005.4M1.2M
 
 
 
Other Uses - Financing86.0K55.0K472.0K0.00
 
 
 
 
Net Cash Flow - Financing28.4M79.8M289.6M1.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-9.0K2.0K-3.0K-5.0K
 
 
 
 
 
 
Net Change In Cash-9.4M13.0M144.5M-141.4M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account